The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
September 16th 2024
For biosimilars to overcome these entrenched market dynamics, they must not only compete on price but actively work to build a network of support among providers and patients.
Biogen Idec Submits Application to FDA for Approval of Oral BG-12 to Treat Multiple Sclerosis
March 1st 2012Yesterday Biogen Idec announced the company has submitted a New Drug Application (NDA) to the FDA for marketing approval of BG-12 (dimethyl fumarate), the company's oral therapeutic candidate for the treatment of multiple sclerosis (MS).
Read More
Walgreens Specialty Pharmacy Shows Cost Savings Through Alternate Treatment Sites
February 25th 2012New data unveiled at the 17th Annual Pharmacy Benefit Management Institute Conference shows patients, health plans and employer groups can save as much as 60 percent through site-of-care optimization.
Read More
AstraZeneca Launches Direct-to-Patient Program for Arimidex
February 17th 2012AstraZeneca recently announced its first direct-to-patient program offering patients with prescriptions for Arimidex (anastrozole) the opportunity to receive their medication for $40 a month through Express Scripts, a specialty pharmacy provider.
Read More
Manufacturer Considerations for Designing a Distribution Strategy for Specialty Products
February 16th 2012As health care costs continue to increase, and with high-cost specialty products making up a significant portion of the pipeline, the role of the Specialty Pharmacy (SP) continues to grow and influence health care decisions across multiple stakeholders.
Read More
Counterfeit Version of Cancer Drug Avastin Distributed in the United States
February 15th 2012The FDA released a statement on February 14, 2012, warning pharmacies, medical practices, and patients that a counterfeit version of the drug Avastin-an injectable drug used to treat cancer of the colon, lung, kidney, and brain-has been purchased and used by some medical practices in the United States.
Read More
CDC Updates HIV Condition Resource
February 11th 2012The Centers for Disease Control and Prevention (CDC) recently added to their list of HIV resources in the Electronic HIV/AIDS Prevention (e-Hap) portion of their website, a section which is produced with content from CDC's Division of HIV/AIDS prevention (DHAP).
Read More
FDA Lists New Drug Interactions for Victrelis
February 9th 2012The FDA sent out a "Drug Safety Communication" from their Division of Drug Information on February 9, 2012, listing the important new drug interactions between Victrelis (boceprevir) and ritonavir-boosted HIV protease inhibitor drugs.
Read More